Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy

about

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy

Item

http://www.wikidata.org/entity/Q57072711

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy

@en

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy

@nl

type

Item

label

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy

@en

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy

@nl

prefLabel

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy

@en

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy

@nl

P1476

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy

@en

P2093

Amir A Jazaeri

http://www.w3.org/2001/XMLSchema#string

Anna V Yemelyanova

http://www.w3.org/2001/XMLSchema#string

Kari L Ring

http://www.w3.org/2001/XMLSchema#string

Khalida M Wani

http://www.w3.org/2001/XMLSchema#string

Michael Frumovitz

http://www.w3.org/2001/XMLSchema#string

Pamela T Soliman

http://www.w3.org/2001/XMLSchema#string

P2860

Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis

Potential immunotherapy targets in recurrent cervical cancer.

A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852).

Improved survival with bevacizumab in advanced cervical cancer

Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators.

Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F

Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis.

Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection.

The arrival of JAK inhibitors: advancing the treatment of immune and hematologic disorders.

Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.

P304

2102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.02102

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alexander J. Lazar

Jason Roszik

P577

2018-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30283446

http://www.w3.org/2001/XMLSchema#string

P932

6156434

http://www.w3.org/2001/XMLSchema#string